Skip to main content
. Author manuscript; available in PMC: 2010 Apr 21.
Published in final edited form as: Clin Chem. 2009 Oct 22;55(12):2171–2179. doi: 10.1373/clinchem.2009.130286

Table 1.

CSF vs serum sPLA2 activity.a

Healthy individuals
(n = 10)
Sex, F/M 3/7
Age, years 53.0 (22.6)
CSF/serum sPLA2 activity ratiob 0.4 (0.1)
CSF/serum protein ratioc 0.013 (0.003)
a

Categorical data (sex) and continuous variables (age, CSF/serum sPLA2 activity ratio, CSF/serum protein ratio) are expressed as number of individuals and as mean (SD), respectively.

b

Whereas CSFs were undiluted, sera were appropriately diluted to get similar protein concentration between CSF and serum-matched samples.

c

Protein concentrations were measured using bicinchoninic acid protein assay (Pierce).

HHS Vulnerability Disclosure